Elder Pharma News Today

KKRs stake in JB Pharma is worth Rs 13,767 crore based on the stocks closing price of Rs 1,649.45 last week

Indian drug manufacturers are utilizing flagship products or "mother brands" to introduce new combinations and establish leadership in therapy areas, as per research by Pharmarack. For example, USVs anti-diabetes drug Glycomet has bolstered the companys reputation in diabetic therapy and facilitated partnerships with multinational drugmakers for innovative therapies.

Analysts see synergies for both Torrent and Dr Reddys with Cipla, driven by rationalisation of costs, but also warn that the merger could significantly raise debt levels for the pharma companies.

Synopsis Another mid-sized pharma firm, La Renon, backed by Sequoia Capital and A91 Partners is also keen on buying out Oaknet. Binding bids will be submitted by this month and the deal is likely to be signed by May 2021, sources said. A clutch of Indian pharmaceutical majors such as Sun Pharmaceutical, Dr Reddys Labs (DRL), KKR-owned JB Chemicals & Pharmaceuticals, Torrent Pharma and Piramal Pharma have shown interest in acquiring Oaknet Healthcare, the Mumbai-based drug formulation manufactu...